GDPD5 and neuroblastoma: Moreover, GDE2 expression strongly correlated with positive clinical outcome in neuroblastoma (Matas-Rico et al., 2016), an often lethal neurodevelopmental malignancy characterized by impaired differentiation (Ratner et al., 2016).